N,N-diethyl-2,5-dimethyl-p-phenylenediamine | 2628-68-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,N-diethyl-2,5-dimethyl-p-phenylenediamine
• 英文别名: N,N-Diaethyl-2,5-dimethyl-p-phenylendiamin；N4,N4-diethyl-2,5-dimethyl-benzene-1,4-diamine；4-N,4-N-diethyl-2,5-dimethylbenzene-1,4-diamine
• CAS: 2628-68-4
• 化学式: C₁₂H₂₀N₂
• 分子量: 192.304
• InChiKey: VSXMMRWKKMCSEP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,4-二氯嘧啶 、 N,N-diethyl-2,5-dimethyl-p-phenylenediamine 在 N,N-二异丙基乙胺 作用下， 以 乙醇 为溶剂， 生成 N-(2-chloro-pyridin-4-yl)-N',N'-diethyl-2,5-dimethyl-benzene-1,4-diamine
  参考文献：
  名称：

  Piperazinyl pyrimidine derivatives as potent γ-secretase modulators

  摘要：

  The development of a novel series of piperazinyl pyrimidines as gamma-secretase modulators for potential use in the treatment of Alzheimer's disease is disclosed herein. Optimization of a screening hit provided a series of potent gamma-secretase modulators with > 180-fold in vitro selectivity over inhibition of Notch cleavage. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.11.101
• 作为产物：
  描述：

  2,5-二甲基苯胺 在 乙醇 、 镍 、 sodium carbonate 作用下， 生成 N,N-diethyl-2,5-dimethyl-p-phenylenediamine
  参考文献：
  名称：

  Chemical Constitution, Electrochemical, Photographic and Allergenic Properties of p-Amino-N-dialkylanilines¹

  摘要：

  DOI：

  10.1021/ja01151a037

文献信息

• Compounds and uses thereof in modulating amyloid beta
  申请人：Cheng Soan

  公开号：US20050070538A1

  公开（公告）日：2005-03-31

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  本发明提供了新的化合物，组合物和试剂盒。还提供了调节Aβ水平的方法，以及治疗与异常Aβ水平相关的疾病的方法。
• COMPOUNDS AND USES THEREOF IN MODULATING AMYLOID BETA
  申请人：Cheng Soan

  公开号：US20070249833A1

  公开（公告）日：2007-10-25

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  提供了新型化合物、组合物和试剂盒。还提供了调节Aβ水平的方法和治疗与异常Aβ水平相关的疾病的方法。
• Compounds and Uses Thereof in Modulating Amyloid Beta
  申请人：Cheng Soan

  公开号：US20070260058A1

  公开（公告）日：2007-11-08

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  本发明提供了新的化合物、组合物和试剂盒。还提供了调节Aβ水平的方法以及治疗与异常Aβ水平相关的疾病的方法。
• PIPERAZINE DERIVATIVES FOR TREATMENT OF AD AND RELATED CONDITIONS
  申请人：Blurton Peter

  公开号：US20100204230A1

  公开（公告）日：2010-08-12

  Compounds of formula (I) selectively inhibit production of Aβ(1-42) and hence find use in treatment of Alzheimer's disease and other conditions associated with deposition of A(β) in the brain.

  公式（I）的化合物选择性地抑制Aβ（1-42）的产生，因此可用于治疗阿尔茨海默病和其他与Aβ在脑中沉积有关的疾病。
• ALPHA-HALOKETONE DERIVATIVES OF IMIDAZOLYL-SUBSTITUTED AROMATIC COMPOUNDS AND COMPOUNDS PREPARED THEREFROM
  申请人：Cheng Soan

  公开号：US20100331551A1

  公开（公告）日：2010-12-30

  Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

  本发明提供了新的化合物、组合物和试剂盒。还提供了调节Aβ水平的方法，以及治疗与异常Aβ水平相关的疾病的方法。